Cargando…
Involvement of erbB4 and tumor marker genes in renal carcinoma regulatory network
BACKGROUND: Renal carcinoma is a common urologic tumor, and there is no ideal tumor marker for clinical diagnosis except for imaging diagnosis. This study aims to screen the serum tumor markers closely related with the benign and malignant of renal carcinoma out and chart out the regulatory network...
Autores principales: | Wang, Xiaofu, Hao, Bin, Xu, Changbao, Zhao, Xinghua, Liu, Changwei, Chu, Xiaohan, Lv, Yuan, Zhao, Yongli, Zhang, Shengwei, Wang, Pengsen, Wang, Youzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851941/ https://www.ncbi.nlm.nih.gov/pubmed/29551924 http://dx.doi.org/10.1016/j.sjbs.2017.11.013 |
Ejemplares similares
-
Study of lung cancer regulatory network that involves erbB4 and tumor marker gene
por: Ma, Xuhui, et al.
Publicado: (2017) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014) -
DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells
por: Bi, Yanli, et al.
Publicado: (2021) -
A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016) -
Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)